Hasegawa Toshinori, Kida Yoshihisa, Kobayashi Tatsuya, Yoshimoto Masayuki, Mori Yoshimasa, Yoshida Jun
Department of Neurosurgery, Gamma Knife Center, Komaki City Hospital, Komaki, Japan.
J Neurosurg. 2005 Jan;102(1):10-6. doi: 10.3171/jns.2005.102.1.0010.
Gamma knife surgery (GKS) has been a safe and effective treatment for vestibular schwannomas in both the short and long term, although less is known about long-term outcomes in the past 10 years. The aim of this study was to clarify long-term outcomes in patients with vestibular schwannomas treated using GKS based on techniques in place in the early 1990s.
Eighty patients harboring a vestibular schwannoma (excluding neurofibromatosis Type 2) were treated using GKS between May 1991 and December 1993. Among these, 73 patients were assessed; seven were lost to follow up. The median duration of follow up was 135 months. The mean patient age at the time of GKS was 56 years old. The mean tumor volume was 6.3 cm3, and the mean maximal and marginal radiation doses applied to the tumor were 28.4 and 14.6 Gy, respectively. Follow-up magnetic resonance images were obtained in 71 patients. Forty-eight patients demonstrated partial tumor remission, 14 had tumors that remained stable, and nine demonstrated tumor enlargement or radiation-induced edema requiring resection. Patients with larger tumors did not fare as well as those with smaller lesions. The actuarial 10-year progression-free survival rate was 87% overall, and 93% in patients with tumor volumes less than 10 cm3. No patient experienced malignant transformation.
Gamma knife surgery remained an effective treatment for vestibular schwannomas for longer than 10 years. Although treatment failures usually occurred within 3 years after GKS, it is necessary to continue follow up in patients to reveal delayed tumor recurrence.
伽玛刀手术(GKS)在短期和长期都是治疗前庭神经鞘瘤的一种安全有效的方法,尽管在过去10年中对其长期疗效了解较少。本研究的目的是根据20世纪90年代初采用的技术,阐明使用GKS治疗的前庭神经鞘瘤患者的长期疗效。
1991年5月至1993年12月期间,80例患有前庭神经鞘瘤(不包括2型神经纤维瘤病)的患者接受了GKS治疗。其中,73例患者接受了评估;7例失访。随访的中位时间为135个月。GKS时患者的平均年龄为56岁。平均肿瘤体积为6.3 cm³,应用于肿瘤的平均最大和边缘辐射剂量分别为28.4 Gy和14.6 Gy。71例患者获得了随访磁共振成像。48例患者肿瘤部分缓解,14例患者肿瘤稳定,9例患者肿瘤增大或出现放射性水肿需要切除。肿瘤较大的患者预后不如肿瘤较小的患者。总体10年无进展生存率为87%,肿瘤体积小于10 cm³的患者为93%。无患者发生恶变。
伽玛刀手术在超过10年的时间里仍然是治疗前庭神经鞘瘤的有效方法。尽管治疗失败通常发生在GKS后3年内,但仍有必要对患者继续进行随访,以发现延迟的肿瘤复发。